Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method
- 701 Downloads
To assess minimally important differences (MIDs) for several pediatric self-report item banks from the National Institutes of Health Patient-Reported Outcomes Measurement Information System® (PROMIS®).
We presented vignettes comprising sets of two completed PROMIS questionnaires and asked judges to declare whether the individual completing those questionnaires had an important change or not. We enrolled judges (including adolescents, parents, and clinicians) who responded to 24 vignettes (six for each domain of depression, pain interference, fatigue, and mobility). We used item response theory to model responses to the vignettes across different judges and estimated MID as the point at which 50 % of the judges would declare an important change.
We enrolled 246 judges (78 adolescents, 85 parents, and 83 clinicians). The MID estimated with clinician data was about 2 points on the PROMIS T-score scale, and the MID estimated with adolescent and parent data was about 3 points on that same scale.
The MIDs enhance the value of PROMIS pediatric measures in clinical research studies to identify meaningful changes in health status over time.
KeywordsPROMIS Pediatrics Self-report Patient-reported outcomes Item response theory Minimally important difference
Patient-Reported Outcomes Measurement Information System®
National Institutes of Health
Minimally important difference
PROMIS® was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund Initiative (Northwestern University, PI: David Cella, PhD, U54AR057951, U01AR052177; Northwestern University, PI: Richard C. Gershon, PhD, U54AR057943; American Institutes for Research, PI: Susan (San) D. Keller, PhD, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, PhD and Arthur A. Stone, PhD, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, MD, MPH, Paul K. Crane, MD, MPH, and Donald L. Patrick, PhD, U01AR057954; University of Washington, Seattle, PI: Dagmar Amtmann, PhD, U01AR052171; University of North Carolina, Chapel Hill, PI: Harry A. Guess, MD, PhD (deceased), Darren A. DeWalt, MD, MPH, U01AR052181; Children’s Hospital of Philadelphia, PI: Christopher B. Forrest, MD, PhD, U01AR057956; Stanford University, PI: James F. Fries, MD, U01AR052158; Boston University, PIs: Alan Jette, PT, PhD, Stephen M. Haley, PhD (deceased), and David Scott Tulsky, PhD (University of Michigan, Ann Arbor), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna, MD (University of Michigan, Ann Arbor) and Brennan Spiegel, MD, MSHS, U01AR057936; University of Pittsburgh, PI: Paul A. Pilkonis, PhD, U01AR052155; Georgetown University, PIs: Carol. M. Moinpour, PhD (Fred Hutchinson Cancer Research Center, Seattle) and Arnold L. Potosky, PhD, U01AR057971; Children’s Hospital Medical Center, Cincinnati, PI: Esi M. Morgan DeWitt, MD, MSCE, U01AR057940; University of Maryland, Baltimore, PI: Lisa M. Shulman, MD, U01AR057967; and Duke University, PI: Kevin P. Weinfurt, PhD, U01AR052186). NIH Science Officers on this project have included Deborah Ader, PhD, Vanessa Ameen, MD (deceased), Susan Czajkowski, PhD, Basil Eldadah, MD, PhD, Lawrence Fine, MD, DrPH, Lawrence Fox, MD, PhD, Lynne Haverkos, MD, MPH, Thomas Hilton, PhD, Laura Lee Johnson, PhD, Michael Kozak, PhD, Peter Lyster, PhD, Donald Mattison, MD, Claudia Moy, PhD, Louis Quatrano, PhD, Bryce Reeve, PhD, William Riley, PhD, Peter Scheidt, MD, Ashley Wilder Smith, PhD, MPH, Susana Serrate-Sztein, MD, William Phillip Tonkins, DrPH, Ellen Werner, PhD, Tisha Wiley, PhD, and James Witter, MD, PhD. We thank Catriona Mowbray, PhD, RN at the Children’s National Health System site, as well as Susan Massengill at Levine Children’s Hospital and Rasheed Gbadegesin at Duke University for important contributions, and Karon Cook, PhD, and Ron Hays, PhD, for very helpful comments on an earlier draft. The contents of this article use data developed under PROMIS. These contents do not necessarily represent an endorsement by the US Federal Government or PROMIS. See www.nihpromis.org for additional information on the PROMIS® initiative. We would also like to acknowledge Susan Massengill at Levine Children’s Hospital and Rasheed Gbadegesin at Duke University, as they led the MID work for sampling the nephrotic syndrome population at these institutions.
Compliance with Ethical Standards
Conflict of interest
Darren DeWalt has copyright of the items in the PROMIS scales tested in this study. He has granted unrestricted license for use of the items to the PROMIS Health Organization and receives no payment or royalties for their use.
- 5.Bellamy, N., Anastassiades, T. P., Buchanan, W. W., Davis, P., Lee, P., McCain, G. A., et al. (1991). Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs—Results of a consensus development (Delphi) exercise. Journal of Rheumatology, 18(12), 1908–1915.PubMedGoogle Scholar
- 6.Bellamy, N., Buchanan, W. W., Esdaile, J. M., Fam, A. G., Kean, W. F., Thompson, J. M., et al. (1991). Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs—Results of a consensus development (Delphi) exercise. Journal of Rheumatology, 18(11), 1716–1722.PubMedGoogle Scholar
- 9.Wyrwich, K. W., Metz, S. M., Kroenke, K., Tierney, W. M., Babu, A. N., & Wolinsky, F. D. (2007). Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease. Health Services Research, 42(6 Pt 1), 2257–2274. doi: 10.1111/j.1475-6773.2007.00733.x.
- 13.Dempster, H., Porepa, M., Young, N., & Feldman, B. M. (2001). The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis and Rheumatism, 44(8), 1768–1774. doi: 10.1002/1529-0131(200108)44:8<1768:AID-ART312>3.0.CO;2-Q.PubMedCrossRefGoogle Scholar
- 15.Kingston, N. M., Kahl, S. R., Sweeney, K. P., & Bay, L. (2001). Setting performance standards using the body of work method. In G. J. Cizek (Ed.), Setting performance standards: Concepts, methods, and perspectives (pp. 219–248). Mahwah, NJ: Lawrence Erlbaum Associates Inc.Google Scholar
- 17.Cook, K. F., Victorson, D. E., Cella, D., Schalet, B. D., & Miller, D. (2015). Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning and sleep disturbance using standard setting with patients and providers. Quality of Life Research, 24(3), 575–589. doi: 10.1007/s11136-014-0790-9.PubMedCrossRefGoogle Scholar
- 18.Irwin, D. E., Stucky, B., Langer, M. M., Thissen, D., Dewitt, E. M., Lai, J. S., et al. (2010). An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 19(4), 595–607. doi: 10.1007/s11136-010-9619-3.CrossRefGoogle Scholar
- 19.Varni, J. W., Stucky, B. D., Thissen, D., Dewitt, E. M., Irwin, D. E., Lai, J. S., et al. (2010). PROMIS Pediatric Pain Interference Scale: An item response theory analysis of the Pediatric Pain Item Bank. Journal of Pain, 11(11), 1109–1119. doi: 10.1016/j.jpain.2010.02.005.PubMedPubMedCentralCrossRefGoogle Scholar
- 20.Lai, J. S., Stucky, B. D., Thissen, D., Varni, J. W., Dewitt, E. M., Irwin, D. E., et al. (2013). Development and psychometric properties of the PROMIS® pediatric fatigue item banks. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,. doi: 10.1007/s11136-013-0357-1.Google Scholar
- 21.Dewitt, E. M., Stucky, B. D., Thissen, D., Irwin, D. E., Langer, M., Varni, J. W., et al. (2011). Construction of the eight-item Patient-Reported Outcomes Measurement Information System pediatric physical function scales: Built using item response theory. Journal of Clinical Epidemiology, 64(7), 794–804. doi: 10.1016/j.jclinepi.2010.10.012.PubMedPubMedCentralCrossRefGoogle Scholar
- 22.Qualtrics. (2013). Qualtrics research suite (version 37892). Provo, UT.Google Scholar
- 25.Yost, K. J., Eton, D. T., Garcia, S. F., & Cella, D. (2011). Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. Journal of Clinical Epidemiology, 64(5), 507–516. doi: 10.1016/j.jclinepi.2010.11.018.PubMedPubMedCentralCrossRefGoogle Scholar
- 26.Copay, A. G., Glassman, S. D., Subach, B. R., Berven, S., Schuler, T. C., & Carreon, L. Y. (2008). Minimum clinically important difference in lumbar spine surgery patients: A choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. The Spine Journal, 8(6), 968–974. doi: 10.1016/j.spinee.2007.11.006.PubMedCrossRefGoogle Scholar
- 28.Demyttenaere, K., Desaiah, D., Petit, C., Croenlein, J., & Brecht, S. (2009). Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder. Primary Care Companion to the Journal of Clinical Psychiatry, 11(1), 8–15. doi: 10.4088/PCC.08m00670.PubMedPubMedCentralCrossRefGoogle Scholar